Rubio, Rodrigo E.

HRN: 12-12-60  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2023
CEFTAZIDIME 1GM (VIAL)
12/12/2023
12/19/2023
IV
1g
Q8
CAP MR, COPD In AE
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: